BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16720210)

  • 1. The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.
    Riemersma SA; Jordanova ES; Haasnoot GW; Drabbels J; Schuuring E; Schreuder GM; Kluin PM
    Hum Immunol; 2006; 67(4-5):303-10. PubMed ID: 16720210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-related hepatocellular carcinoma and B-cell lymphoma patients show a different profile of major histocompatibility complex class II alleles.
    De Re V; Caggiari L; Talamini R; Crovatto M; De Vita S; Mazzaro C; Cannizzaro R; Dolcetti R; Boiocchi M
    Hum Immunol; 2004 Nov; 65(11):1397-404. PubMed ID: 15556690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma.
    Jordanova ES; Philippo K; Giphart MJ; Schuuring E; Kluin PM
    Immunogenetics; 2003 Jul; 55(4):203-9. PubMed ID: 12756506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system.
    Jordanova ES; Riemersma SA; Philippo K; Giphart-Gassler M; Schuuring E; Kluin PM
    Genes Chromosomes Cancer; 2002 Sep; 35(1):38-48. PubMed ID: 12203788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma.
    Booman M; Douwes J; Glas AM; Riemersma SA; Jordanova ES; Kok K; Rosenwald A; de Jong D; Schuuring E; Kluin PM
    Clin Cancer Res; 2006 May; 12(9):2698-705. PubMed ID: 16675561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.
    Riemersma SA; Jordanova ES; Schop RF; Philippo K; Looijenga LH; Schuuring E; Kluin PM
    Blood; 2000 Nov; 96(10):3569-77. PubMed ID: 11071656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia.
    De Re V; Caggiari L; Monti G; Libra M; Spina M; Dolcetti R; De Zorzi M; Racanelli V; Crovatto M; Toffoli G
    Tissue Antigens; 2010 Feb; 75(2):127-35. PubMed ID: 20002609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
    Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
    J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of HLA class II genes with systemic sclerosis in Koreans.
    Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
    J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA; Rimsza LM; Murphy SP
    Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.
    Cejkova P; Novota P; Cerna M; Kolostova K; Novakova D; Kucera P; Novak J; Andel M; Weber P; Zdarsky E
    Int J Immunogenet; 2008 Apr; 35(2):133-40. PubMed ID: 18279373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary study of HLA class II alleles in Thai patients with non Hodgkin's lymphoma.
    Nathalang O; Tatsumi N; Hino M; Yamane T; Prayoonwiwat W; Suwanasophon C; Sriphaisal T
    Osaka City Med J; 1997 Dec; 43(2):253-8. PubMed ID: 9540346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HLA class II polymorphism using polymerase chain reaction.
    Erlich H; Bugawan T; Begovich A; Scharf S
    Arch Pathol Lab Med; 1993 May; 117(5):482-5. PubMed ID: 8489336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leucocyte antigen class II DRB1 and DQB1 associations in human immunodeficiency virus-infected patients of Mumbai, India.
    Shankarkumar U; Pawar A; Ghosh K; Bajpai S; Pazare A
    Int J Immunogenet; 2010 Jun; 37(3):199-204. PubMed ID: 20345872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.
    Kuzushita N; Hayashi N; Moribe T; Katayama K; Kanto T; Nakatani S; Kaneshige T; Tatsumi T; Ito A; Mochizuki K; Sasaki Y; Kasahara A; Hori M
    Hepatology; 1998 Jan; 27(1):240-4. PubMed ID: 9425943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
    Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G
    Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.
    Nowak J; Kalinka-Warzocha E; Juszczynski P; Bilinski P; Mika-Witkowska R; Zajko M; Bienvenu J; Coiffier B; Salles G; Warzocha K
    Genes Chromosomes Cancer; 2007 May; 46(5):500-7. PubMed ID: 17311253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309.
    Praditpornsilpa K; Kupatawintu P; Mongkonsritagoon W; Supasyndh O; Jootar S; Intarakumthornchai T; Pongskul C; Prasithsirikul W; Achavanuntakul B; Ruangkarnchanasetr P; Laohavinij S; Eiam-Ong S
    Nephrol Dial Transplant; 2009 May; 24(5):1545-9. PubMed ID: 18689790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.